Keyphrases
Non-small Cell Lung Cancer (NSCLC)
68%
Tumor
64%
Adenocarcinoma
57%
High-risk Human Papillomavirus (HR-HPV)
49%
Adjuvant Chemotherapy
40%
Carcinoma in Situ
38%
Chemotherapy
36%
Clinical Outcomes
33%
Adenosquamous Carcinoma
32%
Invasive Adenocarcinoma
32%
Immunohistochemical Profile
31%
Cervical Adenosquamous Carcinoma
31%
Overall Survival
27%
Immunohistochemistry
26%
Fertility Preservation
25%
Ovarian Cancer
25%
Prognostic Value
23%
Cancer Cells
23%
Ovulation
22%
HPV-related Cancers
21%
Invasive Stratified mucin-producing Carcinoma
20%
Virtual Pathology
20%
Borderline Ovarian Tumor
20%
Klotho
20%
High-grade Serous Carcinoma
20%
Transplantation
20%
Differential Diagnosis
17%
MicroRNA
16%
Gastric Carcinoma
16%
Cisplatin
16%
Hazard Ratio
15%
Cell-to-cell
15%
KRAS mutation
15%
Cervical Carcinoma
15%
Adenocarcinoma Cells
14%
Liver
14%
Vinorelbine
14%
Malignancy
14%
Squamous Cell Carcinoma (SqCC)
14%
Fertility Sparing
14%
Array Comparative Genomic Hybridization (aCGH)
14%
Patient Selection
13%
Gene Copy number
13%
Drug Combination
13%
Paclitaxel
13%
Immunophenotypic Profile
13%
Formalin-fixed Paraffin-embedded Tissue
13%
Usual Type
13%
Glandular Differentiation
13%
Endocervical
13%
Medicine and Dentistry
Adenocarcinoma
100%
Neoplasm
94%
Non Small Cell Lung Cancer
52%
Wart Virus
43%
Adjuvant Chemotherapy
38%
Carcinoma
38%
Overall Survival
36%
Adenosquamous Carcinoma
32%
Ovarian Cancer
31%
Diseases
28%
Biological Marker
25%
Squamous Cell Carcinoma
24%
Fertility Preservation
24%
Ovarian Tumor
24%
Protein P53
24%
Recurrent Disease
23%
Mucin
22%
Serous Carcinoma
21%
Cancer
21%
Morphology
21%
Cancer Cell
20%
Small Cell Lung Cancer
20%
Immunohistochemistry
20%
Lymph Node Metastasis
17%
Lung Cancer
17%
Fallopian Tube
16%
Malignant Neoplasm
16%
Diagnosis
16%
Differential Diagnosis
15%
Ovulation
15%
Epithelial Cell
15%
Carcinogenesis
14%
Vinorelbine
14%
Cisplatin
14%
Hormone Determination
13%
Metastatic Carcinoma
13%
Cohort Analysis
13%
Primary Tumor
13%
Lymphovascular Invasion
12%
Krukenberg Tumor
12%
In Vitro Fertilisation
12%
Tubulin
12%
Cervix
12%
Progression Free Survival
11%
Lung Tumor
11%
Neuroendocrine Carcinoma
11%
Hazard Ratio
10%
Gene Dosage
10%
Calcifying Epithelial Odontogenic Tumor
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%